Bioverativ to Present at the 2018 J.P. Morgan Healthcare Conference
January 02 2018 - 4:15PM
Business Wire
Bioverativ Inc. (NASDAQ: BIVV) announced today that it will
present at the 2018 J.P. Morgan Healthcare Conference. The event
will be webcast live on Monday, January 8, 2018 at 4:00 p.m. PST.
To access the live webcast, please visit Bioverativ’s Investors
page at investors.bioverativ.com. An archived version of the
webcast will be available following the presentation.
About BioverativBioverativ (NASDAQ: BIVV) is a global
biopharmaceutical company dedicated to transforming the lives of
people with hemophilia and other rare blood disorders through
world-class research, development and commercialization of
innovative therapies. Launched in 2017 following separation from
Biogen Inc., Bioverativ builds upon a strong heritage of scientific
innovation and is committed to actively working with the blood
disorders community. The company’s mission is to create progress
for patients where they need it most and its hemophilia therapies
when launched represented the first major advancements in
hemophilia treatment in more than two decades. For more
information, visit www.bioverativ.com or follow @bioverativ on
Twitter.
View source
version on businesswire.com: http://www.businesswire.com/news/home/20180102005433/en/
INVESTOR CONTACT:BioverativSusan Altschuller, Ph.D., +1
781 663 4360IR@bioverativ.com
Bioverativ Inc. (NASDAQ:BIVV)
Historical Stock Chart
From Jun 2024 to Jul 2024
Bioverativ Inc. (NASDAQ:BIVV)
Historical Stock Chart
From Jul 2023 to Jul 2024